Literature DB >> 32052111

[Intraoperative measurement of parathyroid hormone in hyperparathyroidism].

K Lorenz1, R Schneider2, M Elwerr2.   

Abstract

Intraoperative parathyroid hormone (IOPTH) determination is based on the short half-life of parathyroid hormone (PTH) and the rapid analytical technology. The IOPTH provides functional information regarding correction of the overproductive state in hyperparathyroidism (HPT) and is superior to macroscopic evaluation of the parathyroid gland (PG) as well as any (intraoperative frozen section) form of histology (so-called biochemical frozen section). In this article the relevance and evaluation of IOPTH is defined for the most important forms of HPT, for primary HPT, renal secondary and tertiary HPT, multiple endocrine neoplasia type 1 (MEN1) and parathyroid carcinoma and clinical scenarios based on the currently available data. It becomes apparent that the additional benefits of IOPTH depend on diverse prerequisites of the specific type of HPT, the diagnostics as well as individual patient factors and strategic considerations for resection. Overall, the costs for IOPTH are comparably low and seem to be justified with respect to the gain in quality. In the hands of specialized endocrine surgeons IOPTH is an essential tool for intraoperative decision-making and quality assurance.

Entities:  

Keywords:  Biochemical frozen section; MEN1; Parathyroid carcinoma; Success criteria; Surgical strategy

Year:  2020        PMID: 32052111     DOI: 10.1007/s00104-020-01123-9

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  2 in total

1.  Predictors of adenoma size and location in primary hyperparathyroidism.

Authors:  Barbara Filser; Verena Uslar; Dirk Weyhe; Navid Tabriz
Journal:  Langenbecks Arch Surg       Date:  2021-04-30       Impact factor: 3.445

2.  Evaluation of diagnostic efficacy for localization of parathyroid adenoma in patients with primary hyperparathyroidism undergoing repeat surgery.

Authors:  Anne Hendricks; Christina Lenschow; Matthias Kroiss; Andreas Buck; Ralph Kickuth; Christoph-Thomas Germer; Nicolas Schlegel
Journal:  Langenbecks Arch Surg       Date:  2021-05-16       Impact factor: 3.445

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.